Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-09-12 Sale | 2022-09-14 4:58 pm | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Operating Officer | 17,344 | $2.15 | $37,290 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-22 Option Award | 2024-02-26 6:05 pm | N/A 2034-02-21 | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Operating Officer | 196,875 | $0 | 196,875 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 5:27 pm | N/A 2033-02-22 | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Operating Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2022-04-08 Option Award | 2022-04-12 5:40 pm | N/A 2023-04-07 | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Operating Officer | 97,498 | $0 | 97,498 (Direct) | View |
| 2022-02-03 Option Award | 2022-02-04 6:24 pm | N/A 2032-02-02 | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Operating Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-01 4:23 pm | N/A 2031-06-30 | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Commercial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2020-11-25 Option Award | 2021-04-29 5:30 pm | 2020-11-25 2030-05-04 | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Commercial Officer | 44,000 | $0 | 44,000 (Direct) | View |
| 2021-02-05 Option Award | 2021-02-08 8:27 pm | 2021-02-05 2030-06-19 | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Commercial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-12-17 Option Award | 2020-12-21 5:08 pm | N/A 2030-12-16 | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Commercial Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2020-06-19 Option Award | 2020-06-23 4:33 pm | 2020-06-19 2030-06-18 | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Commercial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2019-11-18 Option Award | 2019-11-21 08:59 am | N/A 2029-11-17 | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Commercial Officer | 125,000 | $0 | 125,000 (Direct) | View |